.
Source: DDInter
Antimuscarinic · Urinary antispasmodic
Also known as tolterodine tartrate
Tolterodine is an anticholinergic drug, exerting antimuscarinic effects. Its use contributes to the overall anticholinergic burden, which can lead to cognitive impairment.
.
Source: DDInter
Clinical effect not specified
Source: DDInter
.
Source: DDInter
Clinical effect not specified
Source: DDInter
Increased plasma levels and effects of tolterodine.
The dose of tolterodine should be halved in patients receiving CYP3A4 inhibitors.
Source: KDT 7e · p118
Increased plasma levels and effects of tolterodine.
The dose of tolterodine should be halved in patients receiving CYP3A4 inhibitors.
Source: DDInter
Increased plasma levels and effects of tolterodine.
The dose of tolterodine should be halved in patients receiving CYP3A4 inhibitors.
Source: DDInter
Increased plasma levels and effects of tolterodine.
The dose of tolterodine should be halved in patients receiving CYP3A4 inhibitors.
Source: DDInter
Increased plasma levels and effects of tolterodine.
The dose of tolterodine should be halved in patients receiving CYP3A4 inhibitors.
Source: DDInter
Increased plasma levels and effects of tolterodine.
The dose of tolterodine should be halved in patients receiving CYP3A4 inhibitors.
Source: DDInter
Increased plasma levels and effects of tolterodine.
The dose of tolterodine should be halved in patients receiving CYP3A4 inhibitors.
Source: DDInter
Increased plasma levels and effects of tolterodine.
The dose of tolterodine should be halved in patients receiving CYP3A4 inhibitors.
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e, Katzung, BNF·Verified: 2026-05-10 · House clinical team